Clinical Trials Browser

Phase 2 × Recruiting × dimethyl-2-(tetrahydro-2-furanyl)ethylsulfonium × Clear all

NCT06241781 2025-02-07

Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients with Recurrent or Metastatic Cervical Cancer

Phase 2 Recruiting

Adult